Public Charity

ALLEN INSTITUTE

Based in SEATTLE, WA, ALLEN INSTITUTE operates as a Public Charity. The organization reported $272.1M in revenue, $270.7M in expenses, $367.1M in total assets for fiscal year 2024. Imperigo tracks 41 reported grant relationships connected to this organization totaling approximately $24.1M.

EIN: 912155317 SEATTLE, WA Neurology & Neuroscience Research NTEE: H96 Latest filing: 2024
Total Revenue$272.1M
Total Expenses$270.7M
Total Assets$367.1M
Grant Records41
Funding Total$24.1M
Filing Years2019–2024

Mission

THE MISSION OF THE ALLEN INSTITUTE IS TO UNLOCK THE COMPLEXITIES OF BIOSCIENCE AND ADVANCE OUR KNOWLEDGE TO IMPROVE HUMAN HEALTH. USING AN OPEN SCIENCE, MULTI-SCALE, TEAM-ORIENTED APPROACH. THE ALLEN INSTITUTE FOCUSES ON ACCELERATING FOUNDATIONAL RESEARCH, (SEE SCHEDULE O) DEVELOPING STANDARDS AND MODELS, AND CULTIVATING NEW IDEAS TO MAKE A BROAD, TRANSFORMATIONAL IMPACT ON SCIENCE.

Where $100 goes at Allen Institute

How Allen Institute divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.

$81 Programs the work itself
$19 Management running the organization
$0 Fundraising none reported

No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.

Inside the $81 for programs

$81
The Allen Institute is dedicated to answering some of the biggest questions in bioscience and accelerating research worldwide
All program spending
Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2024. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Sample Grants Received

2025
Circuit-Selective Whole SCN1A Gene Delivery for Dravet Syndrome. This research focuses on delivering a full-length functional gene specifically to affected neural circuits rather than broadly across the brain utilizing different mouse models of Dravet syndrome. The goal is to improve therapeutic precision while minimizing off-target effects. Using advanced vector systems and targeting strategies, the team aims to restore gene function in key cell populations responsible for disease symptoms. This approach seeks to enhance efficacy and safety of gene therapy by tailoring delivery to the most relevant neural networks.
$449,785
$127,376
2024
SPONSORED RESEARCH SUB-AWARD
$5,168,359
2024
PEDIATRIC MEDICAL RESEARCH GRANT SUBAWARD
$963,932
2024
SUB-AWARD
$622,909

Showing up to 5 of 41 total records — full history available with membership.

Officers & Directors

DIRECTOR Allan Jones
DIRECTOR Alta Charo
EXECUTIVE VP, DIR. ALLEN I Ananda Goldrath
CHIEF TECHNOLOGY OFFICER Andrew Hickl
DIRECTOR Aviv Regev
DIRECTOR Carla Dewberry

Officer compensation and complete director data available with membership.

Top Grant Purposes

Health & Medicine
$9,692,566 17 grants
Research & Policy
$7,783,305 13 grants
Fundraising & Sponsorship
$5,208,748 2 grants
General Support
$818,654 3 grants
Education
$560,041 5 grants

Financial Trends

Year Revenue Expenses Assets
2024 $272.1M $270.7M $367.1M
2023 $240.4M $220.6M $351.4M
2022 $184.2M $177.0M $317.7M
2020 $66.1M $133.8M $154.2M
2019 $68.8M $131.5M $220.9M

Between 2019 and 2024, reported annual revenue grew from $68.8M to $272.1M (+295%), with total assets most recently reported at $367.1M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for ALLEN INSTITUTE

Complete financials, all 41 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time